Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1HIV Infections 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Doxorubicin 5tecogalan 4Liposomes 4Vincristine 3Bleomycin 3Semaxinib 2Mitoxantrone 2Alitretinoin 2ziconotide 1vesnarinone 1tin etiopurpurin 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1Zidovudine 1Tumor Necrosis Factor-alpha 1Sugars 1Ro 24-7429 1Ritonavir 1Paclitaxel 1Nelfinavir 1Mitoguazone 1Maltose 1Interferon-alpha 1Inosine Pranobex 1Fluconazole 1Etoposide 1Daunorubicin 1Dapsone 1Cidofovir 1Bexarotene 1Amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × HIV Infections × Inosine Pranobex × Clear all
NCT00002059 2005-06-24

A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers

NIH AIDS Clinical Trials Information Service

Phase NA Completed

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡